Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF

BACKGROUND: Administration of recombinant luteinizing hormone (rLH) in controlled ovarian hyperstimulation may benefit a subpopulation of patients. However, late follicular phase administration of high doses of rLH may also reduce the size of the follicular cohort and promote monofollicular developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Jessica B, Browne, Aimee S, Copland, Susannah D, Session, Donna R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855615/
https://www.ncbi.nlm.nih.gov/pubmed/20331901
http://dx.doi.org/10.1186/1477-7827-8-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855615/
https://www.ncbi.nlm.nih.gov/pubmed/20331901
http://dx.doi.org/10.1186/1477-7827-8-29

Ejemplares similares